Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ABBV NYSE:IBM NYSE:O On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$248.060.0%$226.15$184.63▼$261.64$438.31B0.39.03 million shs4.14 million shsIBMInternational Business Machines$290.46+1.0%$264.95$212.34▼$332.46$270.27B0.687.52 million shs5.00 million shsORealty Income$64.10+1.3%$61.99$55.86▼$67.93$59.04B0.725.79 million shs5.32 million shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie+0.02%-2.63%+9.02%+17.96%+28.98%IBMInternational Business Machines+0.91%-3.04%+6.88%+20.88%+2.52%ORealty Income+1.20%+1.49%+2.31%+0.46%+12.19%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$248.060.0%$226.15$184.63▼$261.64$438.31B0.39.03 million shs4.14 million shsIBMInternational Business Machines$290.46+1.0%$264.95$212.34▼$332.46$270.27B0.687.52 million shs5.00 million shsORealty Income$64.10+1.3%$61.99$55.86▼$67.93$59.04B0.725.79 million shs5.32 million shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie+0.02%-2.63%+9.02%+17.96%+28.98%IBMInternational Business Machines+0.91%-3.04%+6.88%+20.88%+2.52%ORealty Income+1.20%+1.49%+2.31%+0.46%+12.19%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABBVAbbVie 2.84Moderate Buy$266.247.33% UpsideIBMInternational Business Machines 2.64Moderate Buy$306.285.45% UpsideORealty Income 2.44Hold$66.653.97% UpsideCurrent Analyst Ratings BreakdownLatest ABBV, IBM, and O Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/13/2026ABBVAbbVie UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$230.00 ➝ $260.007/13/2026ABBVAbbVie BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$258.00 ➝ $300.007/10/2026ABBVAbbVie Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$260.00 ➝ $295.007/10/2026ABBVAbbVie Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$234.00 ➝ $276.007/10/2026ABBVAbbVie Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$260.00 ➝ $280.007/10/2026IBMInternational Business Machines SusquehannaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageNeutral$303.007/9/2026ABBVAbbVie GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$249.00 ➝ $261.007/9/2026ABBVAbbVie JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$260.00 ➝ $280.007/8/2026ORealty Income Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)7/6/2026ABBVAbbVie HSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$300.007/6/2026ABBVAbbVie Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$240.00 ➝ $265.00(Data available from 7/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABBVAbbVie$61.16B7.17$15.14 per share16.38($1.83) per share-135.55IBMInternational Business Machines$67.54B4.04$17.31 per share16.78$35.03 per share8.29ORealty Income$5.75B10.40$4.02 per share15.95$43.62 per share1.47Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABBVAbbVie$4.23B$2.03122.2015.470.815.79%-576.45%13.39%7/31/2026 (Estimated)IBMInternational Business Machines$10.59B$11.3125.6821.562.7815.61%37.23%7.49%7/22/2026 (Estimated)ORealty Income$1.06B$1.2252.5413.944.9418.94%2.80%1.55%8/5/2026 (Estimated)Latest ABBV, IBM, and O EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/5/2026Q2 2026ORealty Income$0.3937N/AN/AN/A$1.40 billionN/A7/31/2026Q2 2026ABBVAbbVie$3.71N/AN/AN/A$16.78 billionN/A7/22/2026Q2 2026IBMInternational Business Machines$3.02N/AN/AN/A$17.86 billionN/A5/6/2026Q1 2026ORealty Income$1.10$1.13+$0.03$0.33$1.39 billion$1.55 billion4/29/2026Q1 2026ABBVAbbVie$2.59$2.65+$0.06$0.39$14.72 billion$15.00 billion4/22/2026Q1 2026IBMInternational Business Machines$1.81$1.91+$0.10$1.28$15.60 billion$15.92 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthABBVAbbVie$6.922.79%+6.80%340.89%53 YearsIBMInternational Business Machines$6.762.33%+0.61%59.77%30 YearsORealty Income$3.255.07%+4.50%266.39%31 YearsLatest ABBV, IBM, and O DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/18/2026ABBVAbbViequarterly$1.733.19%7/15/20267/15/20268/14/20267/7/2026ORealty Incomemonthly$0.27105.08%7/31/20267/31/20268/14/20266/9/2026ORealty Incomemonthly$0.27105.25%6/30/20266/30/20267/15/20265/14/2026ORealty Incomemonthly$0.27055.29%5/29/20265/29/20266/15/20264/22/2026IBMInternational Business Machinesquarterly$1.692.95%5/8/20265/8/20266/10/20264/14/2026ORealty Incomemonthly$0.27055.05%4/30/20264/30/20265/15/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABBVAbbVieN/A0.800.68IBMInternational Business Machines1.750.800.76ORealty Income0.721.561.56Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABBVAbbVie70.23%IBMInternational Business Machines58.96%ORealty Income70.81%Insider OwnershipCompanyInsider OwnershipABBVAbbVie0.06%IBMInternational Business Machines0.27%ORealty Income0.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABBVAbbVie57,0001.77 billion1.77 billionOptionableIBMInternational Business Machines286,800939.89 million937.35 millionOptionableORealty Income400932.49 million931.56 millionOptionableABBV, IBM, and O HeadlinesRecent News About These CompaniesMattern Capital Management LLC Cuts Stock Holdings in Realty Income Corporation $O6 minutes ago | marketbeat.comRealty Income expands credit facilities and commercial paper programJuly 13 at 7:55 PM | seekingalpha.comRealty Income Recasts and Expands Revolving Credit Facilities to $5.5 Billion and Commercial Paper Programs to $5.5 BillionJuly 13 at 7:55 PM | finance.yahoo.comRealty Income (O) Expands Credit Facilities To $5.5 Billion And Matches Paper CapacityJuly 13 at 7:55 PM | finance.yahoo.comHow Investors May Respond To Realty Income (O) Expanding Its US$5.5 Billion Multicurrency Credit CapacityJuly 13 at 7:55 PM | finance.yahoo.comRealty Income Expands Credit Facilities and Liquidity ProgramsJuly 13 at 5:11 PM | tipranks.comRealty Income Recasts and Expands Revolving Credit Facilities to $5.5 Billion and Commercial Paper Programs to $5.5 BillionJuly 13 at 4:05 PM | prnewswire.comMorrisons and Realty Income discuss £600m property financing deal – reportJuly 13 at 2:55 PM | retail-insight-network.comRRealty Income's Europe Push: Will It Drive Long-Term Growth Ahead?July 13 at 2:55 PM | finance.yahoo.comMorrisons plots £600m deal to fund fightback against LidlJuly 13 at 2:55 PM | uk.finance.yahoo.comHow Much of Your Social Security Will You Actually Keep After Taxes?July 13 at 2:55 PM | 247wallst.comRealty Income's Europe Push: Will It Drive Long-Term Growth Ahead?July 13 at 11:55 AM | zacks.comThe Market Could Crack This Summer: 5 Defensive High-Yielding Dividend Stocks to Buy NowJuly 13 at 8:40 AM | 247wallst.comJ. Safra Sarasin Holding AG Increases Position in Realty Income Corporation $OJuly 13 at 5:59 AM | marketbeat.comKestra Advisory Services LLC Buys 17,915 Shares of Realty Income Corporation $OJuly 13 at 5:04 AM | marketbeat.comDiversify Wealth Management LLC Purchases 28,085 Shares of Realty Income Corporation $OJuly 13 at 3:59 AM | marketbeat.comCandriam S.C.A. Raises Stock Position in Realty Income Corporation $OJuly 13 at 3:43 AM | marketbeat.comLGT Fund Management Co Ltd. Purchases 135,129 Shares of Realty Income Corporation $OJuly 12 at 1:44 PM | marketbeat.comCommonwealth of Pennsylvania Public School Empls Retrmt SYS Raises Stock Holdings in Realty Income Corporation $OJuly 12 at 11:28 AM | marketbeat.com3 High-Yield Dividend Stocks Paying 5% or More That Are Worth Buying NowJuly 12 at 7:20 AM | fool.comHow Much of a $100,000 Retirement Income Do You Actually Get to Spend?July 12 at 7:20 AM | 247wallst.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesAs Stablecoins Keep Growing, These 2 Stocks BenefitBy Nathan Reiff | June 28, 20262 AI Stocks That Could Benefit as AI Moves Beyond the Data CenterBy Thomas Hughes | July 5, 2026SpaceX Was Just the Beginning—2 More Massive IPOs Are on DeckBy Bridget Bennett | June 21, 2026Washington’s Quantum Push Puts IBM and IonQ on the ThroneBy Jeffrey Neal Johnson | June 25, 2026The Quantum Bubble Is Real Enough to Take SeriouslyBy Nathan Reiff | June 30, 2026ABBV, IBM, and O Company DescriptionsAbbVie NYSE:ABBV$248.06 -0.02 (-0.01%) Closing price 07/13/2026 03:59 PM EasternExtended Trading$248.69 +0.63 (+0.25%) As of 06:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.International Business Machines NYSE:IBM$290.46 +2.90 (+1.01%) Closing price 07/13/2026 03:59 PM EasternExtended Trading$282.52 -7.94 (-2.73%) As of 06:22 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services worldwide. The company operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers a hybrid cloud and AI platforms that allows clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. The Consulting segment focuses on skills integration for strategy, experience, technology, and operations by domain and industry. The Infrastructure segment provides on-premises and cloud based server, and storage solutions, as well as life-cycle services for hybrid cloud infrastructure deployment. The Financing segment offers client and commercial financing, facilitates IBM clients' acquisition of hardware, software, and services. The company has a strategic partnership to various companies including hyperscalers, service providers, global system integrators, and software and hardware vendors that includes Adobe, Amazon Web services, Microsoft, Oracle, Salesforce, Samsung Electronics and SAP, and others. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.Realty Income NYSE:O$64.10 +0.79 (+1.25%) Closing price 07/13/2026 03:59 PM EasternExtended Trading$63.77 -0.34 (-0.52%) As of 06:21 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Realty Income, The Monthly Dividend Company, is an S&P 500 company and member of the S&P 500 Dividend Aristocrats index. We invest in people and places to deliver dependable monthly dividends that increase over time. The company is structured as a real estate investment trust ("REIT"), and its monthly dividends are supported by the cash flow from over 15,450 real estate properties (including properties acquired in the Spirit merger in January 2024) primarily owned under long-term net lease agreements with commercial clients. To date, the company has declared 644 consecutive monthly dividends on its shares of common stock throughout its 55-year operating history and increased the dividend 123 times since Realty Income's public listing in 1994 (NYSE: O). More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The SK Hynix IPO and 2027’s AI Memory Squeeze Why Welltower's Growth Story Might Outrun Its Rich Valuation Why Micron Is Doubling Down While the HBM Shortage Persists AMD's 5C Deal Positions It as a Direct NVIDIA Rival China's Helium Ban Could Reshape the AI Supply Chain The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions Analysts See Major Upside for These 5 Stocks One Short- and One Long-Term ETF for Quantum Computing Bulls Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
